{
    "clinical_study": {
        "@rank": "8241", 
        "arm_group": [
            {
                "arm_group_label": "Low Molecular Weight Heparin", 
                "arm_group_type": "Active Comparator", 
                "description": "Low molecular weight heparin, 2500 milli-International unit/day, subcutaneously"
            }, 
            {
                "arm_group_label": "Low dose aspirin", 
                "arm_group_type": "Active Comparator", 
                "description": "Low dose aspirin, 75mg/day, orally"
            }, 
            {
                "arm_group_label": "Heparin &  Aspirin", 
                "arm_group_type": "Active Comparator", 
                "description": "Heparin (40 mg/day, subcutaneously) and aspirin (70 mg/day, orally)"
            }, 
            {
                "arm_group_label": "Sodium chloride  (NaCl)", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Equivalent volume of NaCl 0.9%, subcutaneously"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to determine whether low-dose aspirin and low molecular weight\n      heparin improve the implantation and pregnancy rates in patients with repeated implantation\n      failures in IVF cycle."
        }, 
        "brief_title": "Effects of Aspirin and Low Molecular Weight Heparin in IVF Outcome.", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "To Investigate the Effects of Low Dose Aspirin and Low Molecular Weight Heparin in IVF Out Come", 
        "detailed_description": {
            "textblock": "The investigators hypothesize that cotreatment of low dose aspirin & low molecular weight\n      heparin  may improve implantation & clinical pregnancy rates."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Aged between 19 to 35 years;\n\n          -  Basal follicle-stimulating hormone (FSH) levels of \u22648 IU/l\n\n          -  Body mass index (BMI) between 19 kg/m2 and 25 kg/m2\n\n          -  Presence of both ovaries; \u22652 previous IVF failures\n\n          -  Good quality embryos for transfer\n\n          -  Endometrial thickness between 10 mm and 14 mm\n\n        Exclusion Criteria:\n\n          -  Polycystic ovary syndrome\n\n          -  Endometriosis"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "35 Years", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": {
            "#text": "400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01924104", 
            "org_study_id": "JJH2013"
        }, 
        "intervention": [
            {
                "arm_group_label": "Low Molecular Weight Heparin", 
                "description": "2500 mIU/day, subcutaneously", 
                "intervention_name": "Low molecular weight heparin", 
                "intervention_type": "Drug", 
                "other_name": "LMWH"
            }, 
            {
                "arm_group_label": "Low dose aspirin", 
                "description": "75 mg/day, orally", 
                "intervention_name": "Low dose aspirin", 
                "intervention_type": "Drug", 
                "other_name": "Ecoaspirin"
            }, 
            {
                "arm_group_label": "Heparin &  Aspirin", 
                "description": "Aspirin (70 mg/day, orally) & heparin (40 mg/day, subcutaneously)", 
                "intervention_name": "Heparin & aspirin", 
                "intervention_type": "Drug", 
                "other_name": "LMWH & Ecoaspirin"
            }, 
            {
                "arm_group_label": "Sodium chloride  (NaCl)", 
                "description": "Equivalent volume of NaCl 0.9%, subcutaneously", 
                "intervention_name": "NaCl", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Aspirin", 
                "Heparin", 
                "Calcium heparin", 
                "Heparin, Low-Molecular-Weight", 
                "Dalteparin"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "IVF failure, implantation rate, heparin & aspirin", 
        "lastchanged_date": "August 15, 2013", 
        "location": {
            "contact": {
                "email": "bansal.drvandana@gmail.com", 
                "last_name": "Vandana Bansal, MS DGO PhD", 
                "phone": "+91-0532-2417252", 
                "phone_ext": "402"
            }, 
            "contact_backup": {
                "email": "arpitivf@gmail.com", 
                "last_name": "Ashwani K Bansal, MS", 
                "phone": "+91-0532-2417252", 
                "phone_ext": "403"
            }, 
            "facility": {
                "address": {
                    "city": "Allahabad", 
                    "country": "India", 
                    "state": "Uttar Pradesh", 
                    "zip": "211003"
                }, 
                "name": "Arpit Test Tube Baby Centre, Jeevan Jyoti Hospital & Research Centre"
            }, 
            "investigator": {
                "last_name": "Vandana Bansal, MS DGO PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "4", 
        "official_title": "Effects of Low Dose Aspirin and Low Molecular Weight Heparin Cotreatment, Alone and/or in Combination on Implantation and Clinical Pregnancy Rates in Repeated Implantation Failures in IVF Cycle.", 
        "overall_contact": {
            "email": "bansal.drvandana@gmail.com", 
            "last_name": "Vandana Bansal, MS DGO PhD", 
            "phone": "+91-0532-2417252", 
            "phone_ext": "402"
        }, 
        "overall_contact_backup": {
            "email": "arpitivf@gmail.com", 
            "last_name": "Ashwani K Bansal, MS", 
            "phone": "+91-0532-2417252", 
            "phone_ext": "403"
        }, 
        "overall_official": {
            "affiliation": "Arpit Test Tube Baby Centre, Vandana Women's Hospital, Jeevan Jyoti Hospital & Research Centre", 
            "last_name": "Vandana Bansal, MS DGO PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "India: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Biological pregnancy test", 
            "safety_issue": "Yes", 
            "time_frame": "14 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01924104"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Jeevan Jyoti Hospital", 
            "investigator_full_name": "Dr.Vandana Bansal", 
            "investigator_title": "Director & Consultant", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Fetal heart/Gestational sac", 
            "safety_issue": "Yes", 
            "time_frame": "8 weeks"
        }, 
        "source": "Jeevan Jyoti Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Dr.Vandana Bansal", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}